Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fortive Corporation stock logo
FTV
Fortive
$60.68
-0.5%
$60.68
$46.34
$64.33
$18.50B1.063.41 million shs1.60 million shs
Nova Ltd. stock logo
NVMI
Nova
$453.63
+4.7%
$506.54
$232.73
$615.99
$14.42B1.74426,662 shs363,734 shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.41
+3.3%
$1.43
$1.09
$2.73
$436.39M2.296.56 million shs6.70 million shs
10x Genomics stock logo
TXG
10x Genomics
$47.11
+9.0%
$32.61
$11.16
$47.19
$5.98B2.052.84 million shs1.93 million shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fortive Corporation stock logo
FTV
Fortive
-1.12%-1.97%+0.02%+0.04%+20.95%
Nova Ltd. stock logo
NVMI
Nova
-0.98%-4.32%-24.71%-17.92%+55.70%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-5.56%-8.72%-2.86%-21.39%-0.73%
10x Genomics stock logo
TXG
10x Genomics
-1.19%+3.47%+24.34%+88.16%+255.72%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Fortive Corporation stock logo
FTV
Fortive
$60.68
-0.5%
$60.68
$46.34
$64.33
$18.50B1.063.41 million shs1.60 million shs
Nova Ltd. stock logo
NVMI
Nova
$453.63
+4.7%
$506.54
$232.73
$615.99
$14.42B1.74426,662 shs363,734 shs
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$1.41
+3.3%
$1.43
$1.09
$2.73
$436.39M2.296.56 million shs6.70 million shs
10x Genomics stock logo
TXG
10x Genomics
$47.11
+9.0%
$32.61
$11.16
$47.19
$5.98B2.052.84 million shs1.93 million shs
7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Fortive Corporation stock logo
FTV
Fortive
-1.12%-1.97%+0.02%+0.04%+20.95%
Nova Ltd. stock logo
NVMI
Nova
-0.98%-4.32%-24.71%-17.92%+55.70%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-5.56%-8.72%-2.86%-21.39%-0.73%
10x Genomics stock logo
TXG
10x Genomics
-1.19%+3.47%+24.34%+88.16%+255.72%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Fortive Corporation stock logo
FTV
Fortive
2.00
Hold$62.913.68% Upside
Nova Ltd. stock logo
NVMI
Nova
2.73
Moderate Buy$556.6722.71% Upside
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
1.80
Reduce$1.8330.49% Upside
10x Genomics stock logo
TXG
10x Genomics
2.20
Hold$32.08-31.90% Downside

Current Analyst Ratings Breakdown

Latest TXG, PACB, FTV, and NVMI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/17/2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
Reiterated RatingSell (E+)
7/17/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetMarket Perform$23.00 ➝ $40.00
7/15/2026
10x Genomics stock logo
TXG
10x Genomics
Reiterated RatingHold
7/14/2026
Nova Ltd. stock logo
NVMI
Nova
Reiterated RatingOverweight$600.00
7/14/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetBuy$32.00 ➝ $50.00
7/9/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetEqual Weight$22.00 ➝ $37.00
7/8/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetNeutral$24.00 ➝ $45.00
7/7/2026
Nova Ltd. stock logo
NVMI
Nova
DowngradeHold (C+)Hold (C)
7/6/2026
Nova Ltd. stock logo
NVMI
Nova
Boost Price TargetEqual Weight$494.00 ➝ $540.00
7/2/2026
Fortive Corporation stock logo
FTV
Fortive
Boost Price TargetHold$61.00 ➝ $67.00
7/1/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetNeutral$20.00 ➝ $42.00
(Data available from 7/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Fortive Corporation stock logo
FTV
Fortive
$4.24B4.37$4.16 per share14.60$20.34 per share2.98
Nova Ltd. stock logo
NVMI
Nova
$880.58M16.37$10.03 per share45.24$44.84 per share10.12
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
$160.01M2.73$0.77 per share1.82$0.02 per share70.25
10x Genomics stock logo
TXG
10x Genomics
$642.82M9.30N/AN/A$6.24 per share7.55
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Fortive Corporation stock logo
FTV
Fortive
$579.20M$1.6736.3319.02N/A12.84%12.66%6.98%7/29/2026 (Estimated)
Nova Ltd. stock logo
NVMI
Nova
$259.22M$8.0256.5637.833.1729.21%21.77%12.56%8/6/2026 (Estimated)
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$546.38M-$0.43N/AN/AN/A-80.35%-571.06%-18.82%8/3/2026 (Estimated)
10x Genomics stock logo
TXG
10x Genomics
-$43.54M-$0.17N/AN/AN/A-3.55%-2.86%-2.23%8/6/2026 (Estimated)

Latest TXG, PACB, FTV, and NVMI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/6/2026Q2 2026
Nova Ltd. stock logo
NVMI
Nova
$2.41N/AN/AN/A$250.33 millionN/A
8/6/2026Q2 2026
10x Genomics stock logo
TXG
10x Genomics
-$0.23N/AN/AN/A$146.67 millionN/A
8/3/2026Q2 2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.1280N/AN/AN/A$42.90 millionN/A
7/29/2026Q2 2026
Fortive Corporation stock logo
FTV
Fortive
$0.71N/AN/AN/A$1.07 billionN/A
5/14/2026Q1 2026
Nova Ltd. stock logo
NVMI
Nova
$2.20$2.33+$0.13$2.04$227.02 million$235.31 million
5/7/2026Q1 2026
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
-$0.17-$0.12+$0.05-$0.03$39.94 million$37.18 million
5/7/2026Q1 2026
10x Genomics stock logo
TXG
10x Genomics
-$0.29-$0.10+$0.19-$0.10$146.41 million$150.84 million
4/30/2026Q1 2026
Fortive Corporation stock logo
FTV
Fortive
$0.64$0.70+$0.06$0.44$1.04 billion$2.14 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Fortive Corporation stock logo
FTV
Fortive
$0.240.40%+5.57%14.37%2 Years
Nova Ltd. stock logo
NVMI
Nova
N/AN/AN/AN/AN/A
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/AN/AN/AN/AN/A
10x Genomics stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A

Latest TXG, PACB, FTV, and NVMI Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/9/2026
Fortive Corporation stock logo
FTV
Fortive
quarterly$0.060.39%6/22/20266/22/20267/6/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Fortive Corporation stock logo
FTV
Fortive
0.43
0.71
0.57
Nova Ltd. stock logo
NVMI
Nova
N/A
1.58
1.39
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A
5.65
4.87
10x Genomics stock logo
TXG
10x Genomics
N/A
5.90
5.42

Institutional Ownership

CompanyInstitutional Ownership
Fortive Corporation stock logo
FTV
Fortive
94.94%
Nova Ltd. stock logo
NVMI
Nova
82.99%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
N/A
10x Genomics stock logo
TXG
10x Genomics
84.68%

Insider Ownership

CompanyInsider Ownership
Fortive Corporation stock logo
FTV
Fortive
0.65%
Nova Ltd. stock logo
NVMI
Nova
1.00%
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
3.70%
10x Genomics stock logo
TXG
10x Genomics
8.84%
CompanyEmployeesShares OutstandingFree FloatOptionable
Fortive Corporation stock logo
FTV
Fortive
10,000304.86 million302.88 millionOptionable
Nova Ltd. stock logo
NVMI
Nova
1,61231.78 million31.47 millionOptionable
Pacific Biosciences of California, Inc. stock logo
PACB
Pacific Biosciences of California
730310.60 million299.11 millionOptionable
10x Genomics stock logo
TXG
10x Genomics
1,240126.96 million115.73 millionOptionable

Recent News About These Companies

Contrasting 10x Genomics (NASDAQ:TXG) and Mitesco (OTCMKTS:MITI)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Fortive stock logo

Fortive NYSE:FTV

$60.68 -0.31 (-0.51%)
Closing price 03:59 PM Eastern
Extended Trading
$60.68 +0.01 (+0.01%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

Nova stock logo

Nova NASDAQ:NVMI

$453.63 +20.46 (+4.72%)
Closing price 03:59 PM Eastern
Extended Trading
$452.86 -0.76 (-0.17%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging. The company serves various sectors of the integrated circuit manufacturing industry, including logic, foundries, and memory manufacturers, as well as process equipment manufacturers. Nova Ltd. was formerly known as Nova Measuring Instruments Ltd. and changed its name to Nova Ltd. in July 2021. Nova Ltd. was incorporated in 1993 and is headquartered in Rehovot, Israel.

Pacific Biosciences of California stock logo

Pacific Biosciences of California NASDAQ:PACB

$1.40 +0.05 (+3.31%)
Closing price 03:59 PM Eastern
Extended Trading
$1.40 -0.01 (-0.36%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$47.11 +3.89 (+9.00%)
Closing price 03:59 PM Eastern
Extended Trading
$47.14 +0.03 (+0.06%)
As of 04:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.